Global Anal and Colorectal Cancer Market Research and Forecast 2018-2023

  • ID: 4471493
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Sep 30th 2018
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Atara Biotherapeutics Inc
  • Boehringer Ingelheim
  • Epigenomics
  • Isa Pharmaceuticals BV
  • Oryx Gmbh & Co Kg
  • MORE
Colorectal cancer is a malignant tumor that starts in the cells of the colon or the rectum while it takes place in anus in case of anal cancer. Rising prevalence of anal and colorectal cancer due to poor lifestyles such as obesity and tobacco consumption has been the major factor driving the market growth. Colorectal cancer is the third most common malignancy and fourth leading cause of cancer-related mortalities globally. It accounts for around 1.4 million incidences and more than 700,000 fatalities across the globe. As per American Cancer Society, around 8,580 new cases of anal cancer are expected in 2018. Additionally, increasing geriatric population and rising anal and colorectal cancer associated with them is another factor driving the market growth. Moreover, high prevalence of smokers and alcohol consumers which are most prone to this cancer has been boosting the market growth. According to WHO, in 2015, more than 1.1 billion people accounted for tobacco smoking and around 2 billion people consumed alcoholic drinks globally. These people have more risk of developing anal cancer and such high prevalence reflects the demand of treatment among population in major countries.

High cost of anal and colorectal cancer treatment along with low awareness towards this cancer act as major restraints for the market growth. However, ongoing improvements in the healthcare expenditure and rising demand of anal and colorectal cancer treatment are expected to drive the market in the developing countries. Additionally, rising demand of minimally invasive surgeries and technological advancement for the treatment of the cancer is expected to boost the market in future.

On the basis of the geography, anal and colorectal cancer market is segmented into North America, Asia Pacific, Europe and Rest of the World. North America has been predicted to dominate the global anal and colorectal cancer market due to well established health infrastructure and high prevalence of this cancer towards people. Additionally, APAC will be the fastest growing region during the forecasted period due to rising geriatric population and increasing incidence and prevalence rate of anal and colorectal cancer.

The key players in the anal and colorectal cancer market Include Abbott Diagnostics, Alere, Taiwan Liposome Company Ltd., Merck & Co., Quest Diagnostics, Roche Ltd., and Taiho Pharmaceutical. FDA Clearance has been recorded as the major breakthrough in the anal and colorectal cancer market. For instance, Roche got the FDA clearance of CE-marked Ventana MMR IHC Panel in November, 2017 for clinicians with a broad portfolio of immunohisto chemistry (IHC) tests for colorectal cancers patients.

Market Segmentation:

Global anal and colorectal cancer market has been segmented on the basis of diagnosis type, by treatment type and by end users. On the basis of diagnosis type, the market has been segmented into colorectal diagnosis and anal cancer diagnosis. Additionally, the market has been segmented on the basis of treatment type into surgery, chemotherapy, radiation therapy, targeted therapy and immuno therapy. Moreover, on the basis of end users, the market is segmented into hospitals, ambulatory surgery centers and cancer research centers. Global Anal and colorectal cancer market is bifurcated as follows:
  • Global Anal and colorectal Cancer Market Research and Analysis, By Diagnosis Type
  • Global Anal and colorectal Cancer Market Research and Analysis, By Treatment Type
  • Global Anal and colorectal Cancer Market Research and Analysis, By End-Users
The Report Covers:
  • Comprehensive research methodology of Global Anal and colorectal Cancer Market.
  • This report also includes detailed and extensive market overview with current market recommendations & key analysts insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Anal and colorectal Cancer Market.
  • Insights about market determinants which are stimulating the Global Anal and colorectal Cancer Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Atara Biotherapeutics Inc
  • Boehringer Ingelheim
  • Epigenomics
  • Isa Pharmaceuticals BV
  • Oryx Gmbh & Co Kg
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Patent Analysis

3. Market Determinant
3.1. Motivators
3.1.1. Rising Number of Anal and Colorectal Cancer
3.1.2. Growing Obese Population
3.1.3. Increasing Prevalence of Human Papillomavirus
3.1.4. Availability of Reimbursement Policies
3.2. Restraints
3.2.1. High Cost of Treatment
3.2.2. Lack of Awareness in Emerging Economies
3.3. Opportunities
3.3.1. R&D and Technological Advancement
3.3.2. Emerging Market in Developing Countries
3.3.3. Rising Demand of Minimally INVasive Surgeries

4. Market Segmentation
4.1. Anal and Colorectal Cancer Market, by Diagnosis
4.1.1. Colorectal Cancer Diagnosis
4.1.1.1. Digital Rectal Examination
4.1.1.2. Biopsy
4.1.1.3. Fecal Occult Blood Test
4.1.1.4. Flexible Sigmoidoscopy
4.1.1.5. Colonoscopy
4.1.2. Anal Cancer Diagnosis
4.1.2.1. Digital Rectal Examination
4.1.2.2. Anoscopy and Protoscopy
4.1.2.3. Biopsy
4.1.2.4. Imaging
4.1.2.4.1. Mri
4.1.2.4.2. Ct-Scan
4.1.2.4.3. Pet-Ct Scan
4.2. Anal and Colorectal Cancer Market, by Treatment
4.2.1. Surgery
4.2.2. Radiation Therapy
4.2.3. Colorectal Cancer Chemotherapy
4.2.3.1. Adenocarcinomas
4.2.3.2. Carcinoid Tumors
4.2.3.3. Lymphomas
4.2.3.4. Sarcomas
4.2.3.5. Gastrointestinal Stromal Tumors (Gists)
4.2.4. Targeted Therapy
4.2.5. Immunotheraphy
4.3. Anal and Colorectal Cancer Market, by End Users
4.3.1. Hospitals
4.3.2. Ambulatory Surgery Centres
4.3.3. Cancer Research Centers

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Diagnostics
7.2. Advaxis Inc
7.3. Alere
7.4. Amgen Inc
7.5. Atara Biotherapeutics Inc
7.6. Bayer Ag
7.7. Bayer Healthcare Pharmaceuticals
7.8. Beckman Coulter
7.9. Beigene Ltd
7.10. Boehringer Ingelheim
7.11. Clinical Genomics
7.12. EDP Biotech
7.13. Eli Lilly and Company
7.14. Epigenomics
7.15. Exact Sciences
7.16. Genomictree
7.17. Immunovaccine Inc
7.18. Isa Pharmaceuticals Bv
7.19. Merck & Co Inc
7.20. Metabiomics
7.21. Ono Pharmaceutical Co Ltd
7.22. Oryx Gmbh & Co Kg
7.23. Pds Biotechnology Corp
7.24. Quest Diagnostics
7.25. Randox Laboratories
7.26. Roche Ltd.
7.27. Siemens Healthcare
7.28. Sun Pharma Advanced Research Company Ltd
7.29. Taiho Pharmaceutical
7.30. Taiwan Liposome Company Ltd
7.31. Volition Rx

List of Tables:
Table 1 Anal and Colorectal Cancer Market Research and Analysis, by Diagnosis Type 2017-2023($ Million)
Table 2 Colorectal Cancer Diagnosis Market Research and Analysis, 2017-2023($ Million)
Table 3 Colorectal Cancer Digital Rectal Examination Market Research and Analysis, 2017-2023($ Million)
Table 4 Colorectal Cancer Fecal Occult Blood Test Market Research and Analysis, 2017-2023($ Million)
Table 5 Colorectal Cancer Flexible Sigmoidoscopy Market Research and Analysis, 2017-2023($ Million)
Table 6 Colorectal Cancer Colonoscopy Market Research and Analysis, 2017-2023($ Million)
Table 7 Colorectal Cancer Biopsy Market Research and Analysis, 2017-2023($ Million)
Table 8 Anal Cancer Diagnosis Market Research and Analysis, 2017-2023($ Million)
Table 9 Anal Cancer Digital Rectal Examination Market Research and Analysis, 2017-2023($ Million)
Table 10 Anal Cancer Anoscopy and Protoscopy Market Research and Analysis, 2017-2023($ Million)
Table 11 Anal Cancer Biopsy Market Research and Analysis, 2017-2023($ Million)
Table 12 Anal Cancer Imaging Market Research and Analysis, 2017-2023($ Million)
Table 13 Anal Cancer Mri Market Research and Analysis, 2017-2023($ Million)
Table 14 Anal Cancer Ct-Scan Market Research and Analysis, 2017-2023($ Million)
Table 15 Anal Cancer Pet-Ct Scan Market Research and Analysis, 2017-2023($ Million)
Table 16 Anal and Colorectal Cancer Market Research and Analysis, by Treatment Type, 2017-2023($ Million)
Table 17 Anal and Colorectal Cancer Surgery Market Research and Analysis, 2017-2023($ Million)
Table 18 Anal and Colorectal Cancer Radiation Therapy Market Research and Analysis, 2017-2023($ Million)
Table 19 Colorectal Cancer Chemotherapy Market Research and Analysis, 2017-2023($ Million)
Table 20 Colorectal Cancer Adenocarcinomas Market Research and Analysis, 2017-2023($ Million)
Table 21 Colorectal Cancer Carcinoid Tumors Market Research and Analysis, 2017-2023($ Million)
Table 22 Colorectal Cancer Lymphomas Market Research and Analysis, 2017-2023($ Million)
Table 23 Colorectal Cancer Sarcomas Market Research and Analysis, 2017-2023($ Million)
Table 24 Colorectal Cancer Gastrointestinal Stromal Tumors (Gists) Market Research and Analysis, 2017-2023($ Million)
Table 25 Anal and Colorectal Cancer Targeted Therapy Market Research and Analysis, 2017-2023($ Million)
Table 26 Anal and Colorectal Cancer Immunotheraphy Market Research and Analysis, 2017-2023($ Million)
Table 27 Anal and Colorectal Cancer Market Research and Analysis, by End Users, 2017-2023($ Million)
Table 28 Anal and Colorectal Cancer Hospitals Market Research and Analysis, 2017-2023($ Million)
Table 29 Anal and Colorectal Cancer Ambulatory Surgery Centres Market Research and Analysis, 2017-2023($ Million)
Table 30 Anal and Colorectal Cancer Research Centers Market Research and Analysis, 2017-2023($ Million)
Table 31 North America Anal and Colorectal Cancer Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 32 North America Anal and Colorectal Cancer Market Research and Analysis, by Treatment 2017-2023($Million)
Table 33 North America Anal and Colorectal Cancer Market Research and Analysis, by End User 2017-2023($Million)
Table 34 North America Anal and Colorectal Cancer Diagnosis and Treatment Market Research and Analysis, by Countries 2017-2023($Million)
Table 35 Europe Anal and Colorectal Cancer Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 36 Europe Anal and Colorectal Cancer Market Research and Analysis, by Treatment 2017-2023($Million)
Table 37 Europe Anal and Colorectal Cancer Market Research and Analysis, by End User 2017-2023($Million)
Table 38 Europe Anal and Colorectal Cancer Diagnosis and Treatment Market Research and Analysis, by Countries 2017-2023($Million)
Table 39 APAC Anal and Colorectal Cancer Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 40 APAC Anal and Colorectal Cancer Market Research and Analysis, by Treatment 2017-2023($Million)
Table 41 APAC Anal and Colorectal Cancer Market Research and Analysis, by End User 2017-2023 ($Million)
Table 42 APAC Anal and Colorectal Cancer Diagnosis and Treatment Market Research and Analysis, by Countries 2017-2023($Million)

List of Figures:
Figure 1 Global Anal and Colorectal Cancer Market Share by Diagnosis Type, 2017 vs 2023 (%)
Figure 2 Global Anal and Colorectal Cancer Market Share by Treatment Type, 2017 vs 2023 (%)
Figure 3 Global Anal and Colorectal Cancer Market Share by End-Users, 2017 vs 2023 (%)
Figure 4 Global Anal and Colorectal Cancer Market Share by Geography, 2017 vs 2023 (%)
Figure 5 North American Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 6 United States Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 7 Canada Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 8 European Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 9 UK Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 10 Germany Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 11 Spain Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 12 France Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 13 Italy Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 14 ROE Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 15 Asia Pacific Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 16 India Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 17 China Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 18 Japan Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 19 RoAPAC Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Figure 20 Rest of the World Anal and Colorectal Cancer Market Size, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Advaxis Inc
  • Alere
  • Amgen Inc
  • Atara Biotherapeutics Inc
  • Bayer Ag
  • Bayer Healthcare Pharmaceuticals
  • Beckman Coulter
  • Beigene Ltd
  • Boehringer Ingelheim
  • Clinical Genomics
  • Edp Biotech
  • Eli Lilly And CoMPany
  • Epigenomics
  • Exact Sciences
  • Genomictree
  • Immunovaccine Inc
  • Isa Pharmaceuticals BV
  • Merck & Co Inc
  • Metabiomics
  • Ono Pharmaceutical Co Ltd
  • Oryx Gmbh & Co Kg
  • Pds Biotechnology Corp
  • Quest Diagnostics
  • Randox Laboratories
  • Roche Ltd.
  • Siemens Healthcare
  • Sun Pharma Advanced Research CoMPany Ltd
  • Taiho Pharmaceutical
  • Taiwan Liposome CoMPany Ltd
  • Volition Rx
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll